Brief: Creative Medical Announces Positive Top-Line Study Results For Chronic Lower Back Pain Utilizing Its Stemspine Procedure Using Allostem Allogenic Cell Line
18/05/2023 13:13
May 18 (Reuters) - Creative Medical Technology Holdings
Inc CELZ.O :
* CREATIVE MEDICAL TECHNOLOGY HOLDINGS ANNOUNCES POSITIVE
TOP-LINE
STUDY RESULTS FOR CHRONIC LOWER BACK PAIN UTILIZING ITS
STEMSPINE® PROCEDURE USING ALLOSTEM™ ALLOGENIC CELL LINE
* CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC - STUDY
DEMONSTRATED
SIGNIFICANT EFFICACY AND NO SERIOUS ADVERSE EVENTS
Source text for Eikon: ID:nPn2KDkMya
Further company coverage: CELZ.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Creative Medical Technology Holdings
See all newsBrief: Creative Medical Technology Buys 4 Million Biodefense Shares For $200,000 Cash And 1 Million Shares On Sept 24
Brief: Creative Medical Technology Holdings Successfully Completes Enrollment And Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation And Phase 3 Planning
Creative Medical Technology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 11:07 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:02 AM